Does CYP3A5 polymorphism influence everolimus intestinal and hepatic metabolism?

被引：0
|
作者：
Rouguieg-Malki, K.
Picard, N.
Marquet, P.
机构：
[1] Univ Limoges, UMR S 850, INSERM, Limoges, France
[2] CHU Limoges, Limoges, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2010年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
346
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [31] Impact of population admixture on the distribution of the CYP3A5*3 polymorphism
    Suarez-Kurtz, Guilherme
    Perini, Jamila A.
    Bastos-Rodrigues, Luciana
    Pena, Sergio D. J.
    Struchiner, Claudio
    PHARMACOGENOMICS, 2007, 8 (10) : 1299 - 1306
  • [32] Genotyping of the A6986G polymorphism of CYP3A5
    Weiss, J
    Haefeli, WE
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (05) : 663 - 663
  • [33] Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin
    Kolovou, Genovefa
    Ragia, Georgia
    Kolovou, Vana
    Mihas, Constantinos
    Katsiki, Niki
    Vasiliadis, Ioannis
    Mavrogeni, Sophie
    Vartela, Vassiliki
    Tavridou, Anna
    Manolopoulos, Vangelis G.
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2014, 8 : 12 - 17
  • [34] Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus
    Kamdem, LK
    Streit, F
    Zanger, UM
    Brockmöller, J
    Oellerich, M
    Armstrong, VW
    Wojnowski, L
    CLINICAL CHEMISTRY, 2005, 51 (08) : 1374 - 1381
  • [35] The relative role of CYP3A4 and CYP3A5 in eplerenone metabolism
    McGraw, Joseph
    Cherney, Mitchell
    Bichler, Katherine
    Gerhardt, Armin
    Nauman, Mirielle
    TOXICOLOGY LETTERS, 2019, 315 : 9 - 13
  • [36] Tacrolimus dose requirement in pediatric liver transplantation: influence of CYP3A5 gene polymorphism
    Durand, Philippe
    Debray, Dominique
    Kolaci, Mikaela
    Bouligand, Jerome
    Furlan, Valerie
    Fabre, Monique
    Letierce, Alexia
    Verstuyft, Celine
    Becquemont, Laurent
    PHARMACOGENOMICS, 2013, 14 (09) : 1017 - 1025
  • [37] The Relative Contributions of CYP3A4 and CYP3A5 to the Metabolism of Vinorelbine
    Topletz, Ariel R.
    Dennison, Jennifer B.
    Barbuch, Robert J.
    Hadden, Chad E.
    Hall, Stephen D.
    Renbarger, Jamie L.
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (09) : 1651 - 1661
  • [38] The influence of genetic CYP3A5 polymorphism on tacrolimus serum concentration in liver transplant patients
    Albsoul-Younes, Abla
    Al-Jabra, Rabia
    Yousef, Almotessem
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1345 - 1345
  • [39] Onset of inhibitory effect of clarithromycin on human intestinal and hepatic cytochrome P4503A (CYP3A) activity and the influence of CYP3A5 genotype.
    Malireddy, S.
    Quinney, S.
    Hamman, M.
    Vuppalanchi, R.
    Pinto, A.
    Chalasani, N.
    Hall, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S5 - S5
  • [40] Possible impact of CYP3A5 polymorphisms on carbamazepine metabolism
    Magliulo, L.
    Viana, M.
    Scordo, M. G.
    Fallarini, S.
    Dahl, M-L.
    Monaco, F.
    Lombardi, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 150 - 150
12345